Literature DB >> 35576773

Insomnia disorder diagnosed by resting-state fMRI-based SVM classifier.

Dongmei He1, Dongmei Ren2, Zhiwei Guo3, Binghu Jiang4.   

Abstract

BACKGROUND: The main classification systems of sleep disorders are based on the subjective self-reported criteria. Objective measures are essential to characterize the nocturnal sleep disturbance, identify daytime impairment, and determine the course of these symptoms. The aim of this study was to establish a resting-state fMRI-based support vector machine (SVM) classifier to diagnose insomnia disorder.
METHODS: We enrolled 20 patients with insomnia disorder and 21 healthy controls, and obtained their simultaneous polysomnographic electroencephalography and functional magnetic resonance imaging (EEG-fMRI) recordings. The SVM classifiers were trained to capture insomnia. Classifier performance was quantified by a 5-fold cross validation and on independent test dataset.
RESULTS: The fMRI-based SVM classifier was able to diagnose insomnia with an accuracy of 89.3% (sensitivity of 90.9%, specificity of 87.7%). The robustness of SVM classifier was encouraging.
CONCLUSIONS: We established an encouraging resting-state fMRI-based SVM classifier to automatically diagnose insomnia disorder. As an objective measure for assessing insomnia disorder, it would be of additional value to the current self-reported subjective criteria.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Insomnia disorder; Machine learning; Magnetic resonance imaging; Support vector machine

Mesh:

Year:  2022        PMID: 35576773     DOI: 10.1016/j.sleep.2022.04.024

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   4.842


  1 in total

1.  Connectomic disturbances underlying insomnia disorder and predictors of treatment response.

Authors:  Qian Lu; Wentong Zhang; Hailang Yan; Negar Mansouri; Onur Tanglay; Karol Osipowicz; Angus W Joyce; Isabella M Young; Xia Zhang; Stephane Doyen; Michael E Sughrue; Chuan He
Journal:  Front Hum Neurosci       Date:  2022-08-10       Impact factor: 3.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.